NCT03369808 - A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine | Biotech Hunter

Enrollment

360

Participants

Timeline

Start Date

December 29, 2017

Primary Completion Date

August 29, 2018

Study Completion Date

November 15, 2019

Conditions

H7N9 Influenza

Interventions

BIOLOGICAL

7.5μg H7N9 Vaccine

The vaccine was a inactivated, whole virion preparation of the influenza A/Shanghai/2/2013(H7N9) virus, propagated in embryonated chicken eggs，mixed with aluminum hydroxide adjuvant.

BIOLOGICAL

Phosphate Buffer Solution

0.5ml phosphate buffer solution

BIOLOGICAL

Aluminum Hydroxide Adjuvant

0.5ml aluminum hydroxide adjuvant

BIOLOGICAL

15μg H7N9 Vaccine

The vaccine was a inactivated, whole virion preparation of the influenza A/Shanghai/2/2013(H7N9) virus, propagated in embryonated chicken eggs，mixed with aluminum hydroxide adjuvant.

BIOLOGICAL

30μg H7N9 Vaccine

The vaccine was a inactivated, whole virion preparation of the influenza A/Shanghai/2/2013(H7N9) virus, propagated in embryonated chicken eggs，mixed with aluminum hydroxide adjuvant.

Trial Locations (1)

463100

Suiping Center for Disease Control and Prevention, Zhumadian

All Listed Sponsors

collaborator

Henan Center for Disease Control and Prevention

OTHER_GOV

lead

Shanghai Institute Of Biological Products

INDUSTRY